Lincoln, NE, United States of America

Marilyn A Larson

This inventor holds 1 USPTO granted patent. Top assignee: The Board of Regents of the University of Nebraska. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marilyn A Larson. Retrieved from https://idiyas.com/inventor/marilyn-a-larson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Marilyn A. Larson

Introduction

Marilyn A. Larson is a prominent inventor based in Lincoln, NE (US). She has made significant contributions to the field of genomics, particularly in the study of mammalian colostrum. Her work has implications for transgenic protocols, showcasing her innovative approach to scientific research.

Latest Patents

Marilyn A. Larson holds 1 patent for her invention titled "Genomic Mammary Amyloid A Sequence." This patent discloses a genomic nucleotide sequence encoding Serum Amyloid A (SAA), which has been isolated and purified from mammalian colostrum. The patent also outlines methods of use for this sequence in transgenic protocols, highlighting its potential applications in biotechnology.

Career Highlights

Marilyn is affiliated with the University of Nebraska, where she continues to advance her research in genomics. Her academic background and ongoing projects contribute to the university's reputation as a leading research institution.

Collaborations

Throughout her career, Marilyn has collaborated with notable colleagues, including Thomas L. McDonald and Annika Weber. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Marilyn A. Larson's innovative work in genomics exemplifies the intersection of science and technology. Her contributions to the field are paving the way for future advancements in transgenic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…